Genome-scale metabolic models in translational medicine: the current status and potential of machine learning in improving the effectiveness of the models.


Journal

Molecular omics
ISSN: 2515-4184
Titre abrégé: Mol Omics
Pays: England
ID NLM: 101713384

Informations de publication

Date de publication:
06 Mar 2024
Historique:
medline: 6 3 2024
pubmed: 6 3 2024
entrez: 6 3 2024
Statut: aheadofprint

Résumé

The genome-scale metabolic model (GEM) has emerged as one of the leading modeling approaches for systems-level metabolic studies and has been widely explored for a broad range of organisms and applications. Owing to the development of genome sequencing technologies and available biochemical data, it is possible to reconstruct GEMs for model and non-model microorganisms as well as for multicellular organisms such as humans and animal models. GEMs will evolve in parallel with the availability of biological data, new mathematical modeling techniques and the development of automated GEM reconstruction tools. The use of high-quality, context-specific GEMs, a subset of the original GEM in which inactive reactions are removed while maintaining metabolic functions in the extracted model, for model organisms along with machine learning (ML) techniques could increase their applications and effectiveness in translational research in the near future. Here, we briefly review the current state of GEMs, discuss the potential contributions of ML approaches for more efficient and frequent application of these models in translational research, and explore the extension of GEMs to integrative cellular models.

Identifiants

pubmed: 38444371
doi: 10.1039/d3mo00152k
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Beste Turanli (B)

Marmara University, Faculty of Engineering, Department of Bioengineering, Istanbul, Turkey. kazim.arga@marmara.edu.tr.
Health Biotechnology Joint Research and Application Center of Excellence, Istanbul, Turkey.

Gizem Gulfidan (G)

Marmara University, Faculty of Engineering, Department of Bioengineering, Istanbul, Turkey. kazim.arga@marmara.edu.tr.

Ozge Onluturk Aydogan (OO)

Marmara University, Faculty of Engineering, Department of Bioengineering, Istanbul, Turkey. kazim.arga@marmara.edu.tr.

Ceyda Kula (C)

Marmara University, Faculty of Engineering, Department of Bioengineering, Istanbul, Turkey. kazim.arga@marmara.edu.tr.
Health Biotechnology Joint Research and Application Center of Excellence, Istanbul, Turkey.

Gurudeeban Selvaraj (G)

Concordia University, Centre for Research in Molecular Modeling & Department of Chemistry and Biochemistry, Quebec, Canada.
Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha Dental College and Hospital, Department of Biomaterials, Bioinformatics Unit, Chennai, India.

Kazim Yalcin Arga (KY)

Marmara University, Faculty of Engineering, Department of Bioengineering, Istanbul, Turkey. kazim.arga@marmara.edu.tr.
Health Biotechnology Joint Research and Application Center of Excellence, Istanbul, Turkey.
Marmara University, Genetic and Metabolic Diseases Research and Investigation Center, Istanbul, Turkey.

Classifications MeSH